Researchers from the Endocrine Tumors group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with ...

Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...

Fellow Health, a company focused on advancing male reproductive health through patient-centric testing solutions, today announced the presentation of four posters at the American Urological ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, presented data today from a study showing that its ...

The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...

The global DNA methylation market is on the verge of a significant surge, with an anticipated market value of USD 1437.5 million in 2023, and projected to skyrocket to USD 5815.49 million by 2033.

Researchers from the Endocrine Tumours group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with five university ...

“Accurate detection of DNA methylation—particularly 5mC and 5hmC—on native molecules is important for advancing research in cancer, human development, and beyond. With the improvements ...

The risk of developing blood cancer increases with age. The finding that a molecule from gut bacteria plays a part points to ...

What's been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

Marijuana, a plant that people often smoke or eat, is becoming more accepted and legal across the United States. It is now ...